Printer Friendly

PERSEPTIVE BIOSYSTEMS ANNOUNCES THE EXERCISE OF THE UNDERWRITERS' OPTION TO PURCHASE 375,000 SHARES, COMPLETING ITS INITIAL PUBLIC OFFERING

PERSEPTIVE BIOSYSTEMS ANNOUNCES THE EXERCISE OF THE UNDERWRITERS' OPTION

TO PURCHASE 375,000 SHARES, COMPLETING ITS INITIAL PUBLIC OFFERING
 CAMBRIDGE, Mass., July 1 /PRNewswire/ -- PerSeptive Biosystems, Inc. (NASDAQ: PBIO) announced today that Alex. Brown & Sons Incorporated and Cowen & Company, the managing underwriters for the company's initial public offering, which commenced on May 29, 1992, exercised their option to purchase an additional 375,000 shares of common stock at a price of $7 per share.
 PerSeptive Biosystems designs, manufactures and markets proprietary products and systems for the purification and analysis of biomolecules. These bioseparations products are designed to reduce significantly the time and cost required for the development and manufacture of biopharmaceuticals. The company's current and planned products for the purification and analysis of biomolecules are based on three interrelated core technologies: Perfusion Chromatography(R), ImmunoDetection(tm), and Rational Surface Design(tm).
 The company's products include a line of over 300 POROS(R) products which consist of a family of consumable chromatography columns and media used to perform Perfusion Chromatography for both purification and analysis and the BioCAD(tm) Workstation, a computer-aided instrumentation system designed to achieve the optimal use of the company's POROS chromatography media for laboratory and development- scale purifications and for analysis.
 Prospectuses may be obtained from Alex. Brown & Sons Incorporated, 135 East Baltimore St., Baltimore, Md. 21202, Attn: David DePietro or Cowen & Company, Financial Square, 27th Floor, New York, N.Y. 10005, Attn: Jack Dunphy.
 This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there by any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 ----
 Note: POROS and Perfusion Chromatography are registered trademarks and BioCAD, ImmunoDetection and Rational Surface Design are trademarks of the company.
 -0- 7/1/92
 /CONTACT: Robert A. Fein, vice president and chief financial officer of PerSeptive Biosystems, 617-621-1787, or Pam Haslam of Feinstein Partners, 617-577-8110, for PerSeptive Biosystems/
 (PBIO) CO: PerSeptive Biosystems, Inc. ST: Massachusetts IN: MTC SU:


SH -- NE006 -- 5600 07/01/92 10:39 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 1, 1992
Words:358
Previous Article:PROPERTY TRUST OF AMERICA ANNOUNCES COMPLETION OF HOLIDAY INN, FISHERMAN'S WHARF ASSEMBLAGE AND SALE OF THREE NON-MULTIFAMILY ASSETS
Next Article:GARY D. OWENS ELECTED TO INPUT/OUTPUT BOARD
Topics:


Related Articles
PERSEPTIVE BIOSYSTEMS ANNOUNCES INITIAL PUBLIC OFFERING
PERSEPTIVE BIOSYSTEMS SUBMITS DRUG MASTER FILE WITH FDA COVERING POROS CHROMATOGRAPHY MEDIA
PERSEPTIVE BIOSYSTEMS NAMES JOHN CURLING VICE PRESIDENT, INTERNATIONAL BUSINESS DEVELOPMENT
OVER-ALLOTMENT OPTION EXERCISED IN MAGAININ PUBLIC OFFERING
PERSEPTIVE BIOSYSTEMS AND ISIS PHARMACEUTICALS SIGN FINAL AGREEMENT TO FORM PERISIS
PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES THIRD QUARTER RESULTS
PERSEPTIVE BIOSYSTEMS ANNOUNCES FILING OF REGISTRATION STATEMENT RELATING TO PERSEPTIVE TECHNOLOGIES II CORP.
PERSEPTIVE BIOSYSTEMS COMMENCES EXCHANGE OFFER FOR UNITS OF PERSEPTIVE TECHNOLOGIES II CORPORATION
MAXIM PHARMACEUTICALS ANNOUNCES UNDERWRITERS EXERCISE OVER-ALLOTMENT OPTION IN INITIAL PUBLIC OFFERING
Transkaryotic Therapies, Inc. Files Registration Statement for Initial Public Offering

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters